Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

KÖSTEK O., HACıOĞLU M., Sakin A., DEMIR T., SARı M., OZKUL O., ...More

Cancer chemotherapy and pharmacology, vol.83, pp.115-122, 2019 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 83
  • Publication Date: 2019
  • Doi Number: 10.1007/s00280-018-3713-6
  • Journal Name: Cancer chemotherapy and pharmacology
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.115-122